You are here

PRİMER HİPERPARATİROİDİZM: KLİNİK ÖZELLİKLERİ, LABORATUVAR VE TEDAVİ SONUÇLARI

Journal Name:

Publication Year:

Abstract (2. Language): 
Primary hyperparathyroidism: Clinical features, laboratory results and outeome. We studi-ed 37 patients with PHPT admİtted to istanbul University Hospital between 1988-1998 years. Paticnts ranged in age from 30 to 69 years (mean 52.97 years), and ineluded 28 women and 9 men. Most patients had bone pain and wcakness. Hypcrtension was deteeted in 11 (29.7) pati-ent. Althought preoperative serum caleium levels were elevated in most patients, one (2.7%) patient's caleium level was in normal limits. With radiological cxamination of bones, we deteeted osteopenia İn 18 (48.6%), subperiosteal resorption in 6 (16.3%), bone eysts in 8 (21.6%), Brown tumours İn 5 (13.5%), salt and pepper appcarance of the skull in 4 (10.8), and pathological fraetures in 5 (13.5%) patients. Nephrolithiasis was present in 9 (24.3) patients. Thirty two (86.5%) patients were operated. Two (5.4%) patients did not accept the operation and medical management was proposed to the three (8.1%) patients. Postoperatİve serum caleium levels did not return to normal levels in three (9.7%) patients. Two of them were reope-rated. Serum caleium levels returned to normal limits after ectopic parathyroid tissues were fo-und and excised. In histopathological cxamination of operated patients, it was determined that 26 (81.2%) patients had parathyroid adenomas, three (9.4%) patients had hypeplasia and two (6.3%) patients had carcinomas. Parathyroid tissue was not found in one patient. Differentia-ted fhyroid carcinoma was diagnosed in four (12.5%) cases. Two of them vvere papillary thyroid carcinoma, the others wcre micropapİUary thyroid carcinoma. At the site of surgicai wound, alarge hematoma occured in one (3.1%) patient. This patients was reoperated and hematom was drained. Temporary postoperative hypoparothyroidism occured in eight (25%) and permanent hypoparathyroİdism in eight (25%) patients
Abstract (Original Language): 
Bu çalışmada, 1988-1998 yıllan arasında İstanbul Tıp Fakültesi Hastanesine başvuran, 28'i kadın (%75.7), 9'u erkek (%24.3) olmak üzere toplam 37 primer hipeıparatiroidizm'H hasta incelendi. Hastaların yaş ortalaması 52.97+9.61 (yaş aralığı 30-69) yıl idi. Hastaların çoğunda (%64.9) kemik ağrısı ve yürüme güçlüğü yakınması vardı. On bir hastada (%29.7) hipertansiyon saptandı. Bir hastada (%2.7) serum kalsiyum düzeyi normal sınırlar içindeydi. Radyolojik incelcmedel8 hastada (%48.6) osteopeni, 6 hastada (%16.3) subperiostal rezorpsiyon, 8 hastada (%21.6) kemik kisti, 5 hastada (%13.5) Brown tümörü, 4 hastada (%10.8) kranİumda tuz-biber görünümü, 5 hastada (%13.5) patolojik kırık görüldü. Dokuz hastada (%24.3) nefrolitia-zis tespit edildi. Otuz iki hasta (%86.5) ameliyat edildi, 2 hasta (%5.4) ameliyatı kabul etmedi, 3 hastaya da (%8.1) takip önerildi. Ameliyat edilen hastaların 3'ündc (%9.7) operasyon sonrası serum kalsiyum düzeyi normale dönmedi. Bunların ikisinde tetkikler sonucunda ektopik para-tiroid bezi bulundu ve yeni bir cerrahi girişimle bez çıkarıldıktan sonra kalsiyum düzeyi normale döndü. Üçüncü hastada ise adenomuıı yeri araştınlamadı. Bir hastada ameliyat esnasında paratiroid adenomu bulunamadı, ancak ameliyat sonrası kalsiyum düzeyi normalin altına inmişti ve histopatolojik incelemede tiroid içinde paratiroid adenomu saptandı. Histopatolojİk incelemede 26 hastada (%81.2) adenom, 3 hastada (%9.4) hiperplazi, 2 hastada (%6.3) paratiroid karsinomu tespit edildi, 1 hastada ise paratiroid dokusuna rastlanmadı. Adenomu olan 3 hastada ve hiperplazi olan 1 hastada olmak üzere toplam 4 hastada (%12.5) birlikte tiroid kanseri saptandı. Bunlardan 2'si papiller, diğer 2'si ise mikropapiîler tiroid kanseri idi. Ameliyat edilen hastaların Tinde (%3.1) ameliyat yerinde büyük bir hematom oluştu, bu hasta ikinci defa ameliyat edildi ve hematom boşaltıldı. Sekiz hastada (%25) geçici, 8 hastada da (%25) kalıcı hipoparatiroİdizm meydana geldi.
24-29

REFERENCES

References: 

1. Al Zahrani A, Lcvine MA: Primary hyperparathyroidism. Lancel 349:1233 (1997).
2. Blezikian JP, Silverberg SJ, Shanc E, et ah Charactcriza-tion and evaluation of asymptomatic primary hyperparathyroidism. J Bone Miner Res 6:85 (199i).
3. Browder W, Rakinic J, Schlcctcr R, Kremcntz ET: Primary hyperparathyroidism in the scventies: A decade of change. Am J Surg 146:360 (1983).
4. Chan AK, Duh OY, Katz Mil ct al: Clinical manifcsalti-ons of primary hipcrparathyroidisnı beforc and after pa-rathyroidcctomy. Ann Surg 222:402 {İ995).
5. Clark OH, Huni TR, Way LVV, et al: Recurrent hyperparathyroidism. Ann Surg 184:391 (1976).
6. Clark OH, Wilkins W, Sıperstein AE, Duh OY: Diagno-sis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiencies in our knowlcd-ge. J Bone Mincr Rcs 6:135 (1991).
7. Clark OH, Duh OY: Primary hyperparathyroidism, a sur-gical perspeetive. Endocrinol Melab Clin North Am 18:701 (1989).
8. Cope O: The sfory of hyperparathyroidism at the Mas-sachussets general hospital. N Engl J Med 274:1174 (1966).
9. Davies M: Primary hyperparathyroidism: aggressive or conservative tıeatment: Clin Endocrinol 36:325 (1992).
10. Diamond TW, Both JR, VVing J et al: Parathyroid hyper-tension: a reversible disorder. Arcİı Intern Med 146:1709 (1986).
11. Fardella C, Rodriquez-Portales JA: Intracellular caleium and blood pressurc: comparison betvveen primary hyperparathyroidism and essential hypeıtension. J Endocrinol invest 18:827 (i995).
12. Grey AB: The skeletal effect of primary hyperparathyroidism. Clin Endocrinol Melab 11:101 (1997).
13. Hayes CW, Conway WF: Hyperparathyroidism. Rad Clin North Am 29:85 (1991).
14. Heath DA, Heath EM: Conservative management of primary hyperparathyroidism. J Bone Miner Res Res 6:117 (İ991).
15. Jlcath H, Hodgson SF, Kenny MA: Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med 302:189 (1980).
16. Kaplan EL, Yashiro T, Salti G: Primary hyperparathyroidism in the 1990: choice of surgical procedures for this disease. Ann Surg 215:300 (19929.
17. Kautzky-Willer A, Pacini G, Niederle B et al: Insulin secretion, insulin sensivity and hepatic insuiin extraction in primary hypeıparathyroidism before and after surgery. Ciin Endocrinol 37:147 (1992).
18. Kremcntz E, YcagerR, Hawley W, WeichcrtR: Thcfirst 100 cases of parathyroid tumor from Charity Hospital of Louisiana. Ann Surg 173:872 (19719.
19. Lafferty FW, Hubay CA: Primary hypeıparathyroidism: a review of the long-lerm surgicai and nonsıırgical mor-bidities as a basis for a approach to treatment. Arch Intern Med 149:789 (1989).
20. Levy FL, Adams-IIuct B: Ambulalory evaluation of nephrolilhiasis: an update of a İ980 protocol. Am J Med 98:50(1995).
21. Mac Farlane MP, Fraker DL, Shawker TH, ct al: Use of preoperative fine-needle aspiration in patients undergo-ing reoperation for primary hyperparathyroidism. Surgery 116:959(1994).
22. Mclton LJ, Atkinson EJ, o'Fallon M, Heath H: Risk of age-related fraetures in patients wilh primary hyperparathyroidism. Arch Inlcm Med 152:2269 (İ992).
23. Midak BH, Daiy M, Polis JT et al: Asymptomatic hyperparathyroidism. J Bone Miner Res 6:103 (1991).
24. Mundy GR, Cove DH, Fishen R: Primary hyperparathyroidism: changes in ihe pallem of clinical preasentation. Lancel 1:1317 (1980).
25. Paloyan E, Lawrencc AM, Oriapas R et al: Subtotal pa-rathyroidcclomy for primary hypeıparathyroidism: long term rcsults İn 292 patients. Arch Surg 118:425 (1983),
26. Silverberg SJ, Blezikian JP: Evaluation and management of primary hypeıparathyroidism. J Clin Endocrinol Me-tab 81:2036 (1996).
27. Stenström G, Heedman PA: Clinicaİ findings in patients witfı hypercalcemia. Açta Med Scan 195:473 (1974).
28. Stevenson JC, Lynn JA: Time to end a conservate treatment for mild hyperparathyroidism. Br Med J 296 (1016 (1988).
29. Slrevvler GJ: Mineral metabolism and meîabolic bone disease. In: Greenspan FS, Strewler GJ (eds). Basic and Clinicaİ Endocrinology. 5th edition, Appleton and Lan-gc, London 263 (1997).
30. Tanaka M, Kim YC, Takasu K el al: Three cases of primary hyperparathyroidism associated with nonmeduliary thyroid carcinoma. IntemMed 34:396 (1995).

Thank you for copying data from http://www.arastirmax.com